Unipharm navigates tricky IPO market to raise €136m
Unipharm, the Irish healthcare services company, has managed to successfully price its €136m IPO in London and Dublin, despite price sensitivity among investors leading to the cancellation of two significant IPOs last week.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts